Literature DB >> 12506690

Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine.

Gary A Gudelsky1, Bryan K Yamamoto.   

Abstract

The existing data indicate that MDMA produces long-term deficits in markers of 5-HT axon terminals in the rodent brain. Increased cleavage of the cytoskeletal protein tau, impairment of axonal transport, and functional consequences associated with a 5-HT depleting regimen of MDMA support the view that MDMA induces structural brain damage, that is, axonal degeneration. A confluence of oxidative stress and bioenergetic stress induced by MDMA is hypothesized to underlie the process of MDMA neurotoxicity (Fig. 3). The actions of MDMA on the 5-HT transporter to promote free radical formation and/or intracellular calcium may synergize with MDMA-induced disturbances in cellular energetics and hyperthermia to effect selective toxicity to 5-HT axon terminals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12506690     DOI: 10.1385/1-59259-358-5:55

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  14 in total

1.  MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

Authors:  Courtney L Huff; Rachel L Morano; James P Herman; Bryan K Yamamoto; Gary A Gudelsky
Journal:  Neurotoxicology       Date:  2016-10-20       Impact factor: 4.294

Review 2.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

3.  Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice.

Authors:  Clara Ros-Simó; Jessica Ruiz-Medina; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2011-12-06       Impact factor: 4.530

4.  MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.

Authors:  John H Anneken; Gary A Gudelsky
Journal:  Neuropharmacology       Date:  2012-07-25       Impact factor: 5.250

5.  DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).

Authors:  F Fornai; P Lenzi; G Frenzilli; M Gesi; M Ferrucci; G Lazzeri; F Biagioni; M Nigro; A Falleni; M Giusiani; A Pellegrini; F Blandini; S Ruggieri; A Paparelli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-13       Impact factor: 4.530

Review 6.  Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Authors:  Gary A Gudelsky; Bryan K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-10-16       Impact factor: 3.533

7.  Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.

Authors:  Jack D Shepard; David T Chuang; Yavin Shaham; Marisela Morales
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

Review 8.  Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?

Authors:  William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

9.  MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Authors:  John H Anneken; Jacobi I Cunningham; Stuart A Collins; Bryan K Yamamoto; Gary A Gudelsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

10.  Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice.

Authors:  Jessica Ruiz-Medina; Ana Pinto-Xavier; Marta Rodríguez-Arias; José Miñarro; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.